Escape of tumor immune surveillance and metastasis

Drug Discovery Today: Disease Models

Volumn 8, Issue 2-3, 2011, Pages 81-86

  Tham, Muly ^a   Abastado, Jean Pierre ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CARCINOGENESIS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSURVEILLANCE; METASTASIS; NONHUMAN; TUMOR IMMUNITY;

EID: 82455164283     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2011.07.004     Document Type: Review

References (40)

1. Chiang, A. C. and Massague, J. (2008) Molecular basis ofmetastasis. N. Engl. J. Med. 359, 2814-2823
2. Nguyen, D. X. et al. (2009) Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284
3. Smyth, M. J. et al. (2006) Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv. Immunol. 90, 1-50 (Pubitemid 43765795)
4. Ostrand-Rosenberg, S. (2008) Immune surveillance: a balance between protumor and antitumor immunity. Curr. Opin. Genet. Dev. 18, 11-18 (Pubitemid 351694442)
5. Na, Y. R. et al. (2009) Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci. 100, 2218-2225
6. van Zijl, F. et al. (2011) A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression. Mol. Cancer Ther. 10, 850-860
7. Kudo-Saito, C. et al. (2009) Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15, 195-206
8. Walrath, J. C. et al. (2010) Genetically engineered mouse models in cancer research. Adv. Cancer Res. 106, 113-164
9. Willimsky, G. and Blankenstein, T. (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437, 141-146 (Pubitemid 41613441)
10. Lengagne, R. et al. (2008) Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases. J. Immunol. 180, 130-137
11. Eyles, J. et al. (2010) Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest. 120, 2030-2039
12. Vesely, M. D. et al. (2011) Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235-271
13. Willimsky, G. et al. (2008) Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J. Exp. Med. 205, 1687-1700 (Pubitemid 351962031)
14. de Visser, K. E. et al. (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411-423 (Pubitemid 40719125)
15. Andreu, P. et al. (2010) FcRgamma activation regulates inflammation associated squamous carcinogenesis. Cancer Cell 17, 121-134
16. Landsberg, J. et al. (2010) Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance. Pigment Cell Melanoma Res. 23, 649-660
17. Grivennikov, S. I. et al. (2010) Immunity, inflammation, and cancer. Cell 140, 883-899
18. Kienast, Y. et al. (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16, 116-122
19. Minn, A. J. et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (Pubitemid 41112921)
20. Bos, P. D. et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009
21. Liu, H. et al. (2010) Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc. Natl. Acad. Sci. U. S. A. 107, 18115-18120
22. Corthay, A. et al. (2009) Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells. Cancer Res. 69, 5901-5907
23. Gabrilovich, D. I. and Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174
24. Yan, H. H. et al. (2010) Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 70, 6139-6149
25. Chauviere, A. H. et al. (2010) Mathematical oncology: how are the mathematical and physical sciences contributing to the war on breast cancer? Curr. Breast Cancer Rep. 2, 121-129
26. Lowengrub, J. S. et al. (2010) Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 23, R1-R9
27. Hatzikirou, H. et al. (2010) 'Go or Grow': the key to the emergence of invasion in tumour progression? Math. Med. Biol.
28. Yachida, S. et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117
29. Meng, S. et al. (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10, 8152-8162 (Pubitemid 40053373)
30. Willis, L. et al. (2010) Breast cancer dormancy can be maintained by small numbers of micrometastases. Cancer Res. 70, 4310-4317
31. Leon, K. et al. (2007) How regulatory CD25 (+) CD4 (+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors J. Theor. Biol. 247, 122-137 (Pubitemid 46783827)
32. Eikenberry, S. et al. (2009) Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma. PLoS Comput. Biol. 5, e1000362
33. Teng, M. W. et al. (2010) Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion. Cancer Res. 70, 2665-2674
34. Kimpfler, S. et al. (2009) Skin melanoma development in ret transgenic micedespite the depletion of CD25+Foxp3+ regulatory Tcellsin lymphoid organs. J. Immunol. 183, 6330-6337
35. Rech, A. J. and Vonderheide, R. H. (2009) Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Ann. N. Y. Acad. Sci. 1174, 99-106
36. Bos, P. D. et al. (2010) Modeling metastasis in the mouse. Curr. Opin. Pharmacol. 10, 571-577
37. Katouli, A. A. and Komarova, N. L. (2011) The worst drug rule revisited: mathematical modeling of cyclic cancer treatments. Bull. Math. Biol. 73, 549-584
38. Castiglione, F. and Piccoli, B. (2007) Cancer immunotherapy, mathematical modeling and optimal control. J. Theor. Biol. 247, 723-732 (Pubitemid 47081044)
39. Rosenberg, S. A. et al. (2004) Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909-915 (Pubitemid 39273730)
40. Francia, G. et al. (2011) Mouse modelsofadvanced spontaneous metastasis for experimental therapeutics. Nat. Rev. Cancer 11, 135-141